

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 3.96653596 |
| 2 | behavioral response to nicotine (GO:0035095) | 3.88545229 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.87703712 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 3.87703712 |
| 5 | neuronal action potential propagation (GO:0019227) | 3.76720617 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.65774089 |
| 7 | positive regulation of synapse maturation (GO:0090129) | 3.62207854 |
| 8 | vocalization behavior (GO:0071625) | 3.56785789 |
| 9 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.54900575 |
| 10 | central nervous system myelination (GO:0022010) | 3.54757866 |
| 11 | axon ensheathment in central nervous system (GO:0032291) | 3.54757866 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 3.53324504 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.53324504 |
| 14 | glutamate secretion (GO:0014047) | 3.45607700 |
| 15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.40357830 |
| 16 | response to methylmercury (GO:0051597) | 3.40132057 |
| 17 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.39757963 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 3.37605663 |
| 19 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.36534307 |
| 20 | membrane depolarization during action potential (GO:0086010) | 3.34666509 |
| 21 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.31901154 |
| 22 | regulation of synapse maturation (GO:0090128) | 3.30704599 |
| 23 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.30282219 |
| 24 | gamma-aminobutyric acid transport (GO:0015812) | 3.24735606 |
| 25 | dendritic spine morphogenesis (GO:0060997) | 3.22570617 |
| 26 | behavioral response to cocaine (GO:0048148) | 3.19443197 |
| 27 | protein localization to synapse (GO:0035418) | 3.18153125 |
| 28 | presynaptic membrane organization (GO:0097090) | 3.16399450 |
| 29 | synaptic vesicle maturation (GO:0016188) | 3.10962866 |
| 30 | presynaptic membrane assembly (GO:0097105) | 3.09970381 |
| 31 | neurotransmitter secretion (GO:0007269) | 3.09137179 |
| 32 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.08157549 |
| 33 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.08009531 |
| 34 | fatty acid elongation (GO:0030497) | 3.07999448 |
| 35 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.07996939 |
| 36 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.06776176 |
| 37 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.05548579 |
| 38 | neuron-neuron synaptic transmission (GO:0007270) | 3.05295695 |
| 39 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.04495363 |
| 40 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.04456806 |
| 41 | cellular ketone body metabolic process (GO:0046950) | 3.03346787 |
| 42 | proline transport (GO:0015824) | 3.00159803 |
| 43 | potassium ion homeostasis (GO:0055075) | 2.99640885 |
| 44 | potassium ion import (GO:0010107) | 2.98624243 |
| 45 | regulation of synaptic vesicle transport (GO:1902803) | 2.98422753 |
| 46 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.98280454 |
| 47 | auditory behavior (GO:0031223) | 2.97819633 |
| 48 | respiratory electron transport chain (GO:0022904) | 2.95747644 |
| 49 | locomotory exploration behavior (GO:0035641) | 2.92878361 |
| 50 | ATP synthesis coupled proton transport (GO:0015986) | 2.92244296 |
| 51 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.92244296 |
| 52 | regulation of synapse structural plasticity (GO:0051823) | 2.91850170 |
| 53 | dicarboxylic acid catabolic process (GO:0043649) | 2.91606039 |
| 54 | C4-dicarboxylate transport (GO:0015740) | 2.91447480 |
| 55 | glutamate receptor signaling pathway (GO:0007215) | 2.90952551 |
| 56 | sodium ion export (GO:0071436) | 2.90743713 |
| 57 | exogenous drug catabolic process (GO:0042738) | 2.90531325 |
| 58 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.90178981 |
| 59 | electron transport chain (GO:0022900) | 2.88776016 |
| 60 | primary amino compound metabolic process (GO:1901160) | 2.87699305 |
| 61 | neuromuscular process controlling posture (GO:0050884) | 2.86442475 |
| 62 | synaptic transmission, glutamatergic (GO:0035249) | 2.84736430 |
| 63 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.82925146 |
| 64 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.82925146 |
| 65 | neuromuscular synaptic transmission (GO:0007274) | 2.81582929 |
| 66 | neuronal ion channel clustering (GO:0045161) | 2.81395080 |
| 67 | aromatic amino acid family catabolic process (GO:0009074) | 2.78992367 |
| 68 | neurotransmitter transport (GO:0006836) | 2.78581212 |
| 69 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.77933646 |
| 70 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.74302229 |
| 71 | drug catabolic process (GO:0042737) | 2.74060708 |
| 72 | cell migration in hindbrain (GO:0021535) | 2.73350995 |
| 73 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.71817548 |
| 74 | positive regulation of dendritic spine development (GO:0060999) | 2.70973898 |
| 75 | aspartate family amino acid catabolic process (GO:0009068) | 2.70081900 |
| 76 | alanine transport (GO:0032328) | 2.70077379 |
| 77 | cellular sodium ion homeostasis (GO:0006883) | 2.69744034 |
| 78 | NADH metabolic process (GO:0006734) | 2.67267021 |
| 79 | regulation of neurotransmitter secretion (GO:0046928) | 2.66825491 |
| 80 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.66702690 |
| 81 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.66361775 |
| 82 | regulation of neurotransmitter transport (GO:0051588) | 2.66196342 |
| 83 | coenzyme catabolic process (GO:0009109) | 2.65287369 |
| 84 | glyoxylate metabolic process (GO:0046487) | 2.64434313 |
| 85 | membrane depolarization (GO:0051899) | 2.63522804 |
| 86 | regulation of catecholamine metabolic process (GO:0042069) | 2.63086994 |
| 87 | regulation of dopamine metabolic process (GO:0042053) | 2.63086994 |
| 88 | succinate metabolic process (GO:0006105) | 2.62573808 |
| 89 | regulation of neurotransmitter levels (GO:0001505) | 2.62551543 |
| 90 | detection of calcium ion (GO:0005513) | 2.62254035 |
| 91 | ketone body metabolic process (GO:1902224) | 2.62246250 |
| 92 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.62157906 |
| 93 | serotonin metabolic process (GO:0042428) | 2.62137731 |
| 94 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.60699027 |
| 95 | nucleobase catabolic process (GO:0046113) | 2.60038073 |
| 96 | transmission of nerve impulse (GO:0019226) | 2.59638385 |
| 97 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.58823448 |
| 98 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.58768317 |
| 99 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.58406088 |
| 100 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.57898730 |
| 101 | auditory receptor cell stereocilium organization (GO:0060088) | 2.56518319 |
| 102 | regulation of glutamate secretion (GO:0014048) | 2.56460501 |
| 103 | long-term synaptic potentiation (GO:0060291) | 2.56110611 |
| 104 | neuron recognition (GO:0008038) | 2.55054816 |
| 105 | glycine transport (GO:0015816) | 2.53962428 |
| 106 | glutamate metabolic process (GO:0006536) | 2.53788261 |
| 107 | negative regulation of neurotransmitter transport (GO:0051589) | 2.53068544 |
| 108 | regulation of membrane repolarization (GO:0060306) | 2.52545127 |
| 109 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.51903813 |
| 110 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.50238548 |
| 111 | regulation of postsynaptic membrane potential (GO:0060078) | 2.50106892 |
| 112 | adult walking behavior (GO:0007628) | 2.49975846 |
| 113 | neurotransmitter uptake (GO:0001504) | 2.49848652 |
| 114 | cell communication by electrical coupling (GO:0010644) | 2.49240581 |
| 115 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.48910508 |
| 116 | regulation of neurotransmitter uptake (GO:0051580) | 2.48668564 |
| 117 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.48581619 |
| 118 | synaptic vesicle endocytosis (GO:0048488) | 2.48418392 |
| 119 | neuronal action potential (GO:0019228) | 2.48218400 |
| 120 | cerebellar granule cell differentiation (GO:0021707) | 2.44531421 |
| 121 | cellular potassium ion homeostasis (GO:0030007) | 2.44367429 |
| 122 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.44180004 |
| 123 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.43912496 |
| 124 | glycosphingolipid biosynthetic process (GO:0006688) | 2.43817326 |
| 125 | synaptic transmission (GO:0007268) | 2.43774826 |
| 126 | regulation of vesicle fusion (GO:0031338) | 2.43668501 |
| 127 | peroxisome fission (GO:0016559) | 2.42921212 |
| 128 | glycerophospholipid catabolic process (GO:0046475) | 2.42899148 |
| 129 | membrane repolarization (GO:0086009) | 2.41971305 |
| 130 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.41904250 |
| 131 | female mating behavior (GO:0060180) | 2.41897056 |
| 132 | long-term memory (GO:0007616) | 2.40893574 |
| 133 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.40523428 |
| 134 | transferrin transport (GO:0033572) | 2.39850721 |
| 135 | chaperone-mediated protein transport (GO:0072321) | 2.39616782 |
| 136 | positive regulation of membrane potential (GO:0045838) | 2.39012480 |
| 137 | phosphorelay signal transduction system (GO:0000160) | 2.38589517 |
| 138 | multicellular organismal signaling (GO:0035637) | 2.38317855 |
| 139 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.38204811 |
| 140 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.37598215 |
| 141 | striatum development (GO:0021756) | 2.36463675 |
| 142 | response to insecticide (GO:0017085) | 2.33533155 |
| 143 | synaptic transmission, dopaminergic (GO:0001963) | 2.31802400 |
| 144 | regulation of oxidative phosphorylation (GO:0002082) | 2.29961916 |
| 145 | regulation of synaptic plasticity (GO:0048167) | 2.28626365 |
| 146 | postsynaptic membrane organization (GO:0001941) | 2.28442178 |
| 147 | exploration behavior (GO:0035640) | 2.27502275 |
| 148 | ferric iron transport (GO:0015682) | 2.27375102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.63778526 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.70246519 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.76052734 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.75546607 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.46733291 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.36391165 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.34745360 |
| 8 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24872386 |
| 9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.24104314 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.23810604 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.23506430 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.22554191 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.18780342 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.18780342 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.16882345 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.10204201 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.02446620 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.02230138 |
| 19 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.97716913 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.92919826 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.92642423 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.89111571 |
| 23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.81103804 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.80094046 |
| 25 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.79034393 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77684181 |
| 27 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.74615709 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.72620468 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.72473641 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.69751554 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.69617314 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69521519 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.69020572 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.66251627 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.66182160 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.66103079 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.61350379 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.59543727 |
| 39 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56648584 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.55117514 |
| 41 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.53187483 |
| 42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52269132 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.49961676 |
| 44 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47269685 |
| 45 | VDR_22108803_ChIP-Seq_LS180_Human | 1.44771135 |
| 46 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43440775 |
| 47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.35717708 |
| 48 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35606869 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35206749 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34444048 |
| 51 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.28907706 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28106375 |
| 53 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.28043650 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27021959 |
| 55 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.26367664 |
| 56 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.24363366 |
| 57 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22487627 |
| 58 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.22369549 |
| 59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22030865 |
| 60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.21669773 |
| 61 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.21499132 |
| 62 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19752186 |
| 63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.19414610 |
| 64 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.15179103 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15092599 |
| 66 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14788020 |
| 67 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12730141 |
| 68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11717284 |
| 69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10444460 |
| 70 | ERA_21632823_ChIP-Seq_H3396_Human | 1.09771505 |
| 71 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07900742 |
| 72 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07588014 |
| 73 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.07452151 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06724698 |
| 75 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06210417 |
| 76 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05315355 |
| 77 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.05030959 |
| 78 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.04668129 |
| 79 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04306500 |
| 80 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.02734300 |
| 81 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01789494 |
| 82 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01337181 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99341417 |
| 84 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.99292620 |
| 85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99250222 |
| 86 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.98898673 |
| 87 | FUS_26573619_Chip-Seq_HEK293_Human | 0.98658737 |
| 88 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97380673 |
| 89 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.95497562 |
| 90 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95402390 |
| 91 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95402390 |
| 92 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.94790340 |
| 93 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94241947 |
| 94 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.93944190 |
| 95 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.93816433 |
| 96 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92189727 |
| 97 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.91240181 |
| 98 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.90817886 |
| 99 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.90698572 |
| 100 | P68_20966046_ChIP-Seq_HELA_Human | 0.89538911 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88890446 |
| 102 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88451057 |
| 103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88243907 |
| 104 | AR_19668381_ChIP-Seq_PC3_Human | 0.87716209 |
| 105 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.87513185 |
| 106 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.86931939 |
| 107 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.86741308 |
| 108 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86724552 |
| 109 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86724552 |
| 110 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.86623765 |
| 111 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.86611088 |
| 112 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86470680 |
| 113 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.86282366 |
| 114 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86127762 |
| 115 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.85533736 |
| 116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85445966 |
| 117 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.85350922 |
| 118 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.85272658 |
| 119 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.85123899 |
| 120 | KDM2B_26808549_Chip-Seq_REH_Human | 0.84692498 |
| 121 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84549753 |
| 122 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83546492 |
| 123 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.82967739 |
| 124 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.82732816 |
| 125 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.82278882 |
| 126 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.82174608 |
| 127 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.81946539 |
| 128 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.81944549 |
| 129 | * NCOR_22424771_ChIP-Seq_293T_Human | 0.80914356 |
| 130 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.80190810 |
| 131 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.80190810 |
| 132 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79457375 |
| 133 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.78685906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.58822946 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.96951413 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.01989266 |
| 4 | MP0009745_abnormal_behavioral_response | 2.81658724 |
| 5 | MP0002064_seizures | 2.76169095 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 2.67932245 |
| 7 | MP0009046_muscle_twitch | 2.61668095 |
| 8 | MP0004270_analgesia | 2.60083788 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.49564382 |
| 10 | MP0002822_catalepsy | 2.46939887 |
| 11 | MP0002272_abnormal_nervous_system | 2.44301247 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.42467375 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.39147034 |
| 14 | MP0001529_abnormal_vocalization | 2.33030568 |
| 15 | MP0002736_abnormal_nociception_after | 2.24655846 |
| 16 | MP0005360_urolithiasis | 2.22755561 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.19191809 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 2.13375474 |
| 19 | MP0001486_abnormal_startle_reflex | 2.11608545 |
| 20 | MP0003329_amyloid_beta_deposits | 2.00544766 |
| 21 | MP0008875_abnormal_xenobiotic_pharmacok | 1.99263303 |
| 22 | MP0004043_abnormal_pH_regulation | 1.99057620 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 1.96041872 |
| 24 | MP0001501_abnormal_sleep_pattern | 1.92957362 |
| 25 | MP0005423_abnormal_somatic_nervous | 1.89376137 |
| 26 | MP0001986_abnormal_taste_sensitivity | 1.86849791 |
| 27 | MP0001440_abnormal_grooming_behavior | 1.85534063 |
| 28 | MP0003787_abnormal_imprinting | 1.83287510 |
| 29 | MP0004142_abnormal_muscle_tone | 1.81949450 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.77234560 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.76004267 |
| 32 | MP0005365_abnormal_bile_salt | 1.75974127 |
| 33 | MP0002067_abnormal_sensory_capabilities | 1.74559139 |
| 34 | MP0004147_increased_porphyrin_level | 1.69644676 |
| 35 | MP0003195_calcinosis | 1.64408255 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.61209139 |
| 37 | MP0001905_abnormal_dopamine_level | 1.59224638 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.57504939 |
| 39 | MP0002735_abnormal_chemical_nociception | 1.56648549 |
| 40 | MP0004924_abnormal_behavior | 1.54929769 |
| 41 | MP0005386_behavior/neurological_phenoty | 1.54929769 |
| 42 | MP0005083_abnormal_biliary_tract | 1.53223414 |
| 43 | MP0001970_abnormal_pain_threshold | 1.51043979 |
| 44 | MP0005551_abnormal_eye_electrophysiolog | 1.50425195 |
| 45 | MP0009780_abnormal_chondrocyte_physiolo | 1.48344025 |
| 46 | MP0000920_abnormal_myelination | 1.47822449 |
| 47 | MP0002733_abnormal_thermal_nociception | 1.46083057 |
| 48 | MP0008569_lethality_at_weaning | 1.42949267 |
| 49 | MP0003690_abnormal_glial_cell | 1.34993556 |
| 50 | MP0001984_abnormal_olfaction | 1.34588280 |
| 51 | MP0008872_abnormal_physiological_respon | 1.33861501 |
| 52 | MP0003633_abnormal_nervous_system | 1.30163702 |
| 53 | MP0003123_paternal_imprinting | 1.29797954 |
| 54 | MP0002653_abnormal_ependyma_morphology | 1.29270608 |
| 55 | MP0005535_abnormal_body_temperature | 1.28213689 |
| 56 | MP0003879_abnormal_hair_cell | 1.28113540 |
| 57 | MP0002229_neurodegeneration | 1.26410908 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.24654951 |
| 59 | MP0000751_myopathy | 1.23554898 |
| 60 | MP0002909_abnormal_adrenal_gland | 1.22570021 |
| 61 | MP0002066_abnormal_motor_capabilities/c | 1.21858739 |
| 62 | MP0003878_abnormal_ear_physiology | 1.21519280 |
| 63 | MP0005377_hearing/vestibular/ear_phenot | 1.21519280 |
| 64 | MP0002557_abnormal_social/conspecific_i | 1.21251267 |
| 65 | MP0001502_abnormal_circadian_rhythm | 1.15841539 |
| 66 | MP0005332_abnormal_amino_acid | 1.14645551 |
| 67 | MP0001485_abnormal_pinna_reflex | 1.10690781 |
| 68 | MP0003631_nervous_system_phenotype | 1.10441811 |
| 69 | MP0004145_abnormal_muscle_electrophysio | 1.10371620 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.09840968 |
| 71 | MP0004885_abnormal_endolymph | 1.09734492 |
| 72 | MP0004215_abnormal_myocardial_fiber | 1.09145510 |
| 73 | MP0010329_abnormal_lipoprotein_level | 1.08866246 |
| 74 | MP0002184_abnormal_innervation | 1.07706637 |
| 75 | MP0006292_abnormal_olfactory_placode | 1.07583501 |
| 76 | MP0002882_abnormal_neuron_morphology | 1.06839750 |
| 77 | MP0000955_abnormal_spinal_cord | 1.05917987 |
| 78 | MP0000604_amyloidosis | 1.05762468 |
| 79 | MP0000778_abnormal_nervous_system | 1.05373656 |
| 80 | MP0000013_abnormal_adipose_tissue | 1.04682406 |
| 81 | MP0008877_abnormal_DNA_methylation | 1.04279555 |
| 82 | MP0003806_abnormal_nucleotide_metabolis | 1.03918671 |
| 83 | MP0001963_abnormal_hearing_physiology | 1.03564965 |
| 84 | MP0002876_abnormal_thyroid_physiology | 1.01304712 |
| 85 | MP0004085_abnormal_heartbeat | 0.99837503 |
| 86 | MP0003136_yellow_coat_color | 0.99597939 |
| 87 | MP0004811_abnormal_neuron_physiology | 0.98109769 |
| 88 | MP0008874_decreased_physiological_sensi | 0.96122380 |
| 89 | MP0004036_abnormal_muscle_relaxation | 0.95960671 |
| 90 | MP0003122_maternal_imprinting | 0.94501467 |
| 91 | MP0010386_abnormal_urinary_bladder | 0.94266488 |
| 92 | MP0003646_muscle_fatigue | 0.92938727 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 0.92804111 |
| 94 | MP0002090_abnormal_vision | 0.91870910 |
| 95 | MP0006035_abnormal_mitochondrial_morpho | 0.89343384 |
| 96 | MP0003121_genomic_imprinting | 0.88440076 |
| 97 | MP0003634_abnormal_glial_cell | 0.88151181 |
| 98 | MP0004133_heterotaxia | 0.87652479 |
| 99 | MP0003011_delayed_dark_adaptation | 0.86204681 |
| 100 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86159053 |
| 101 | MP0001666_abnormal_nutrient_absorption | 0.82879558 |
| 102 | MP0000631_abnormal_neuroendocrine_gland | 0.82539807 |
| 103 | MP0002069_abnormal_eating/drinking_beha | 0.82134028 |
| 104 | MP0004742_abnormal_vestibular_system | 0.81871570 |
| 105 | MP0000749_muscle_degeneration | 0.81634597 |
| 106 | MP0000566_synostosis | 0.81559017 |
| 107 | MP0000747_muscle_weakness | 0.80650822 |
| 108 | MP0002752_abnormal_somatic_nervous | 0.80109383 |
| 109 | MP0003632_abnormal_nervous_system | 0.79040530 |
| 110 | MP0008775_abnormal_heart_ventricle | 0.78622386 |
| 111 | MP0005645_abnormal_hypothalamus_physiol | 0.78568712 |
| 112 | MP0001765_abnormal_ion_homeostasis | 0.78494282 |
| 113 | MP0000026_abnormal_inner_ear | 0.78471661 |
| 114 | MP0004130_abnormal_muscle_cell | 0.78390030 |
| 115 | MP0005253_abnormal_eye_physiology | 0.77907204 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.77424443 |
| 117 | MP0003137_abnormal_impulse_conducting | 0.77376973 |
| 118 | MP0002152_abnormal_brain_morphology | 0.77133855 |
| 119 | MP0005670_abnormal_white_adipose | 0.75596139 |
| 120 | MP0003868_abnormal_feces_composition | 0.71277522 |
| 121 | MP0003252_abnormal_bile_duct | 0.70665499 |
| 122 | MP0005171_absent_coat_pigmentation | 0.70652968 |
| 123 | MP0005448_abnormal_energy_balance | 0.70307636 |
| 124 | MP0009840_abnormal_foam_cell | 0.70259648 |
| 125 | MP0005379_endocrine/exocrine_gland_phen | 0.69866190 |
| 126 | MP0002078_abnormal_glucose_homeostasis | 0.69623167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.72974558 |
| 2 | Myokymia (HP:0002411) | 4.22724764 |
| 3 | Focal seizures (HP:0007359) | 3.73858600 |
| 4 | Epileptic encephalopathy (HP:0200134) | 3.72218335 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 3.63514697 |
| 6 | Visual hallucinations (HP:0002367) | 3.50888199 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.50107612 |
| 8 | Limb dystonia (HP:0002451) | 3.49054586 |
| 9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.48226593 |
| 10 | Acute encephalopathy (HP:0006846) | 3.46310687 |
| 11 | Hyperventilation (HP:0002883) | 3.42411259 |
| 12 | Atonic seizures (HP:0010819) | 3.42083962 |
| 13 | Pheochromocytoma (HP:0002666) | 3.19214651 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.18588717 |
| 15 | Absence seizures (HP:0002121) | 3.18460327 |
| 16 | Progressive macrocephaly (HP:0004481) | 3.15539958 |
| 17 | Abnormal gallbladder physiology (HP:0012438) | 3.12042023 |
| 18 | Cholecystitis (HP:0001082) | 3.12042023 |
| 19 | Febrile seizures (HP:0002373) | 3.06383582 |
| 20 | Neurofibrillary tangles (HP:0002185) | 3.05532977 |
| 21 | Dialeptic seizures (HP:0011146) | 3.03827872 |
| 22 | Cerebral edema (HP:0002181) | 2.94410150 |
| 23 | Hemiparesis (HP:0001269) | 2.91819308 |
| 24 | Cerebral inclusion bodies (HP:0100314) | 2.91509588 |
| 25 | Mitochondrial inheritance (HP:0001427) | 2.91454892 |
| 26 | Abnormality of binocular vision (HP:0011514) | 2.89014739 |
| 27 | Diplopia (HP:0000651) | 2.89014739 |
| 28 | Abnormal gallbladder morphology (HP:0012437) | 2.88148121 |
| 29 | Cholelithiasis (HP:0001081) | 2.86592802 |
| 30 | Congenital stationary night blindness (HP:0007642) | 2.86068888 |
| 31 | Anxiety (HP:0000739) | 2.83616837 |
| 32 | Neuroendocrine neoplasm (HP:0100634) | 2.82627812 |
| 33 | Polyphagia (HP:0002591) | 2.64356539 |
| 34 | Abnormal drinking behavior (HP:0030082) | 2.59706627 |
| 35 | Polydipsia (HP:0001959) | 2.59706627 |
| 36 | Type II lissencephaly (HP:0007260) | 2.57279757 |
| 37 | Hepatocellular necrosis (HP:0001404) | 2.55892414 |
| 38 | Dysmetria (HP:0001310) | 2.53255121 |
| 39 | Leukodystrophy (HP:0002415) | 2.53136712 |
| 40 | Progressive cerebellar ataxia (HP:0002073) | 2.51837179 |
| 41 | Increased CSF lactate (HP:0002490) | 2.51241949 |
| 42 | Ketosis (HP:0001946) | 2.48046167 |
| 43 | Status epilepticus (HP:0002133) | 2.45430607 |
| 44 | Poikilocytosis (HP:0004447) | 2.44692035 |
| 45 | Amblyopia (HP:0000646) | 2.42660458 |
| 46 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.42254539 |
| 47 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.42254539 |
| 48 | Dysdiadochokinesis (HP:0002075) | 2.41755043 |
| 49 | Supranuclear gaze palsy (HP:0000605) | 2.39004457 |
| 50 | Scanning speech (HP:0002168) | 2.37488033 |
| 51 | Cerebral hypomyelination (HP:0006808) | 2.36241674 |
| 52 | Hyperglycinuria (HP:0003108) | 2.32466601 |
| 53 | Ketoacidosis (HP:0001993) | 2.31874149 |
| 54 | Optic disc pallor (HP:0000543) | 2.30164027 |
| 55 | Epileptiform EEG discharges (HP:0011182) | 2.27629376 |
| 56 | Depression (HP:0000716) | 2.27489707 |
| 57 | Hepatic necrosis (HP:0002605) | 2.27104000 |
| 58 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.27087531 |
| 59 | Hyperlipoproteinemia (HP:0010980) | 2.26240750 |
| 60 | Intrahepatic cholestasis (HP:0001406) | 2.24102016 |
| 61 | Nephronophthisis (HP:0000090) | 2.23076378 |
| 62 | Delusions (HP:0000746) | 2.20711165 |
| 63 | EEG with generalized epileptiform discharges (HP:0011198) | 2.18964357 |
| 64 | Abnormality of the corticospinal tract (HP:0002492) | 2.18839758 |
| 65 | Abnormality of glycolysis (HP:0004366) | 2.17633985 |
| 66 | Increased serum pyruvate (HP:0003542) | 2.17633985 |
| 67 | Acanthocytosis (HP:0001927) | 2.16614752 |
| 68 | Action tremor (HP:0002345) | 2.16210796 |
| 69 | Hypochromic microcytic anemia (HP:0004840) | 2.16089039 |
| 70 | Abnormal social behavior (HP:0012433) | 2.15445309 |
| 71 | Impaired social interactions (HP:0000735) | 2.15445309 |
| 72 | Pancreatic cysts (HP:0001737) | 2.14201915 |
| 73 | Genetic anticipation (HP:0003743) | 2.13942862 |
| 74 | Exercise-induced myalgia (HP:0003738) | 2.12899518 |
| 75 | Poor eye contact (HP:0000817) | 2.12383945 |
| 76 | Pancreatic fibrosis (HP:0100732) | 2.12193721 |
| 77 | Progressive inability to walk (HP:0002505) | 2.11957738 |
| 78 | Abnormality of the renal cortex (HP:0011035) | 2.11536874 |
| 79 | Abnormality of alanine metabolism (HP:0010916) | 2.11345138 |
| 80 | Hyperalaninemia (HP:0003348) | 2.11345138 |
| 81 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.11345138 |
| 82 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.10462465 |
| 83 | Gaze-evoked nystagmus (HP:0000640) | 2.10040927 |
| 84 | Confusion (HP:0001289) | 2.09591869 |
| 85 | Delayed CNS myelination (HP:0002188) | 2.09554790 |
| 86 | Broad-based gait (HP:0002136) | 2.08608935 |
| 87 | Polyuria (HP:0000103) | 2.08276392 |
| 88 | Prolonged partial thromboplastin time (HP:0003645) | 2.08185449 |
| 89 | Postural instability (HP:0002172) | 2.06896850 |
| 90 | Syncope (HP:0001279) | 2.06472114 |
| 91 | Truncal ataxia (HP:0002078) | 2.05889248 |
| 92 | Deep venous thrombosis (HP:0002625) | 2.05637003 |
| 93 | Methylmalonic acidemia (HP:0002912) | 2.05254968 |
| 94 | Spastic gait (HP:0002064) | 2.04917299 |
| 95 | Abnormality of the gallbladder (HP:0005264) | 2.04799989 |
| 96 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.04560875 |
| 97 | Prolonged QT interval (HP:0001657) | 2.04296639 |
| 98 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.04098682 |
| 99 | Abnormality of glycine metabolism (HP:0010895) | 2.04098682 |
| 100 | Hyperbilirubinemia (HP:0002904) | 2.03979928 |
| 101 | Hypsarrhythmia (HP:0002521) | 2.03175324 |
| 102 | Bundle branch block (HP:0011710) | 2.01224377 |
| 103 | Progressive microcephaly (HP:0000253) | 2.01070180 |
| 104 | Cerebral hemorrhage (HP:0001342) | 2.01028941 |
| 105 | Abnormal urine output (HP:0012590) | 2.00927065 |
| 106 | Psychosis (HP:0000709) | 2.00502225 |
| 107 | Cystic liver disease (HP:0006706) | 1.99834931 |
| 108 | Lactic acidosis (HP:0003128) | 1.99414465 |
| 109 | Generalized myoclonic seizures (HP:0002123) | 1.98596554 |
| 110 | Sleep apnea (HP:0010535) | 1.98468755 |
| 111 | Drooling (HP:0002307) | 1.97934089 |
| 112 | Retinal atrophy (HP:0001105) | 1.97052585 |
| 113 | Heart block (HP:0012722) | 1.96796729 |
| 114 | Inability to walk (HP:0002540) | 1.96752209 |
| 115 | X-linked dominant inheritance (HP:0001423) | 1.96585094 |
| 116 | Absent speech (HP:0001344) | 1.96452523 |
| 117 | Decreased central vision (HP:0007663) | 1.96317419 |
| 118 | Abnormality of the renal medulla (HP:0100957) | 1.96035532 |
| 119 | Abnormal eating behavior (HP:0100738) | 1.95163337 |
| 120 | Clumsiness (HP:0002312) | 1.93330373 |
| 121 | Intention tremor (HP:0002080) | 1.92911367 |
| 122 | Ankle clonus (HP:0011448) | 1.92781154 |
| 123 | Xanthomatosis (HP:0000991) | 1.92248955 |
| 124 | Molar tooth sign on MRI (HP:0002419) | 1.91642847 |
| 125 | Abnormality of midbrain morphology (HP:0002418) | 1.91642847 |
| 126 | Metabolic alkalosis (HP:0200114) | 1.90604808 |
| 127 | Lethargy (HP:0001254) | 1.90305955 |
| 128 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.90231540 |
| 129 | Spastic tetraplegia (HP:0002510) | 1.89967827 |
| 130 | Respiratory failure (HP:0002878) | 1.89407638 |
| 131 | Focal dystonia (HP:0004373) | 1.89127980 |
| 132 | Metabolic acidosis (HP:0001942) | 1.87778799 |
| 133 | Reticulocytosis (HP:0001923) | 1.87689203 |
| 134 | Increased circulating renin level (HP:0000848) | 1.87226329 |
| 135 | True hermaphroditism (HP:0010459) | 1.86900944 |
| 136 | Lissencephaly (HP:0001339) | 1.86800277 |
| 137 | Ventricular fibrillation (HP:0001663) | 1.84660260 |
| 138 | Blue irides (HP:0000635) | 1.84460565 |
| 139 | Torticollis (HP:0000473) | 1.83549563 |
| 140 | Craniofacial dystonia (HP:0012179) | 1.82127005 |
| 141 | Pachygyria (HP:0001302) | 1.81858689 |
| 142 | Hemiplegia (HP:0002301) | 1.81607749 |
| 143 | Gait imbalance (HP:0002141) | 1.81157829 |
| 144 | Central scotoma (HP:0000603) | 1.78952915 |
| 145 | Termporal pattern (HP:0011008) | 1.78760811 |
| 146 | Insidious onset (HP:0003587) | 1.78760811 |
| 147 | Gout (HP:0001997) | 1.78753974 |
| 148 | Resting tremor (HP:0002322) | 1.78379057 |
| 149 | Hypomagnesemia (HP:0002917) | 1.77279084 |
| 150 | Renal Fanconi syndrome (HP:0001994) | 1.76383137 |
| 151 | Increased intramyocellular lipid droplets (HP:0012240) | 1.75749512 |
| 152 | Abolished electroretinogram (ERG) (HP:0000550) | 1.75550442 |
| 153 | Ulnar claw (HP:0001178) | 1.75419117 |
| 154 | Hypobetalipoproteinemia (HP:0003563) | 1.75219826 |
| 155 | Hyperglycinemia (HP:0002154) | 1.75184153 |
| 156 | Tubular atrophy (HP:0000092) | 1.75092342 |
| 157 | Abnormal EKG (HP:0003115) | 1.75049287 |
| 158 | CNS hypomyelination (HP:0003429) | 1.74466970 |
| 159 | Retinal dysplasia (HP:0007973) | 1.73408790 |
| 160 | Cerebral palsy (HP:0100021) | 1.73192763 |
| 161 | Megalencephaly (HP:0001355) | 1.72665549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.84653381 |
| 2 | NTRK3 | 3.30309669 |
| 3 | CASK | 3.24066226 |
| 4 | MAP3K4 | 3.03289778 |
| 5 | MAP2K7 | 2.66907552 |
| 6 | FRK | 2.49719189 |
| 7 | OXSR1 | 2.39728428 |
| 8 | MAP2K4 | 2.37972129 |
| 9 | MAP3K9 | 2.13047025 |
| 10 | DAPK2 | 2.07187064 |
| 11 | STK39 | 2.00853144 |
| 12 | MAP3K12 | 2.00399178 |
| 13 | CDK19 | 1.85043418 |
| 14 | GRK5 | 1.72210758 |
| 15 | MAP4K2 | 1.68678429 |
| 16 | MINK1 | 1.60033421 |
| 17 | SGK494 | 1.58252282 |
| 18 | SGK223 | 1.58252282 |
| 19 | PLK2 | 1.57407609 |
| 20 | WNK4 | 1.47028837 |
| 21 | PKN1 | 1.44579958 |
| 22 | GRK7 | 1.42873236 |
| 23 | CAMK2B | 1.42175906 |
| 24 | NME1 | 1.41998018 |
| 25 | NTRK1 | 1.39578390 |
| 26 | PHKG1 | 1.39464062 |
| 27 | PHKG2 | 1.39464062 |
| 28 | PAK6 | 1.39092940 |
| 29 | PNCK | 1.38408161 |
| 30 | CAMK2A | 1.34472665 |
| 31 | NTRK2 | 1.29353149 |
| 32 | CDK5 | 1.29254480 |
| 33 | BCKDK | 1.29219873 |
| 34 | KSR2 | 1.28504197 |
| 35 | INSRR | 1.27162979 |
| 36 | PINK1 | 1.25054351 |
| 37 | ARAF | 1.24192799 |
| 38 | GRK1 | 1.23869065 |
| 39 | MAPKAPK5 | 1.23238061 |
| 40 | RIPK4 | 1.22097324 |
| 41 | PRPF4B | 1.21132508 |
| 42 | MARK1 | 1.20537475 |
| 43 | CAMK2D | 1.18652599 |
| 44 | PRKD3 | 1.18080240 |
| 45 | UHMK1 | 1.16941408 |
| 46 | TNIK | 1.16049270 |
| 47 | PRKCG | 1.11903778 |
| 48 | CAMKK2 | 1.10922405 |
| 49 | MAP3K13 | 1.10857753 |
| 50 | MUSK | 1.10444989 |
| 51 | TYRO3 | 1.08853250 |
| 52 | FES | 1.05877284 |
| 53 | TAOK3 | 1.05086013 |
| 54 | CAMK2G | 1.02810869 |
| 55 | MAPKAPK3 | 1.02601673 |
| 56 | PTK2B | 1.01792350 |
| 57 | FGR | 1.01093265 |
| 58 | DAPK1 | 1.00168656 |
| 59 | DYRK2 | 0.94725109 |
| 60 | WNK1 | 0.91796204 |
| 61 | MAPK13 | 0.91739444 |
| 62 | BMPR1B | 0.91067027 |
| 63 | CAMKK1 | 0.90690985 |
| 64 | MAP2K6 | 0.90455384 |
| 65 | BMPR2 | 0.87501524 |
| 66 | PRKCE | 0.84038524 |
| 67 | PRKCH | 0.83843218 |
| 68 | CAMK4 | 0.81801182 |
| 69 | MAPK12 | 0.78477595 |
| 70 | FGFR2 | 0.78199286 |
| 71 | PIK3CA | 0.78036217 |
| 72 | ADRBK2 | 0.77162642 |
| 73 | MAP3K7 | 0.76688597 |
| 74 | SGK2 | 0.76587624 |
| 75 | PRKAA1 | 0.75221114 |
| 76 | ERBB4 | 0.73494041 |
| 77 | ROCK2 | 0.73077917 |
| 78 | AKT3 | 0.71291946 |
| 79 | CDK18 | 0.71039156 |
| 80 | PAK3 | 0.70753543 |
| 81 | CDK15 | 0.70439627 |
| 82 | PDPK1 | 0.70310081 |
| 83 | DYRK1A | 0.70182595 |
| 84 | SGK1 | 0.69878425 |
| 85 | CAMK1 | 0.69728252 |
| 86 | BCR | 0.69539270 |
| 87 | CDK14 | 0.68524328 |
| 88 | PDK3 | 0.66164045 |
| 89 | PDK4 | 0.66164045 |
| 90 | MAP3K2 | 0.66062226 |
| 91 | MYLK | 0.63530495 |
| 92 | LMTK2 | 0.63483885 |
| 93 | CAMK1D | 0.62244957 |
| 94 | ADRBK1 | 0.61980122 |
| 95 | KSR1 | 0.61814466 |
| 96 | MAP3K11 | 0.61348546 |
| 97 | MAP3K1 | 0.60707986 |
| 98 | CSNK1G2 | 0.60707929 |
| 99 | ERBB2 | 0.60259124 |
| 100 | STK11 | 0.60241140 |
| 101 | RPS6KA3 | 0.60161480 |
| 102 | PRKACA | 0.60141291 |
| 103 | DAPK3 | 0.58895799 |
| 104 | WNK3 | 0.58747133 |
| 105 | SGK3 | 0.57828788 |
| 106 | CDK11A | 0.57291283 |
| 107 | PDK1 | 0.56657837 |
| 108 | TLK1 | 0.56463277 |
| 109 | PRKAA2 | 0.56385041 |
| 110 | GRK6 | 0.55658511 |
| 111 | STK38 | 0.55579865 |
| 112 | RET | 0.54784180 |
| 113 | SIK2 | 0.54684446 |
| 114 | PRKCA | 0.52551743 |
| 115 | DYRK1B | 0.51231237 |
| 116 | MARK2 | 0.50782618 |
| 117 | OBSCN | 0.50486174 |
| 118 | MAP3K6 | 0.50429683 |
| 119 | CDC42BPA | 0.50092696 |
| 120 | CSNK1A1 | 0.49793153 |
| 121 | PRKCI | 0.49009563 |
| 122 | TNK2 | 0.48710495 |
| 123 | PRKG1 | 0.48586180 |
| 124 | PRKCZ | 0.47975903 |
| 125 | PRKACG | 0.47404198 |
| 126 | MAP2K1 | 0.47070649 |
| 127 | NUAK1 | 0.45051185 |
| 128 | LIMK1 | 0.43548224 |
| 129 | ZAK | 0.42750687 |
| 130 | EEF2K | 0.41421607 |
| 131 | TRPM7 | 0.41353503 |
| 132 | MAP2K2 | 0.40150454 |
| 133 | BRSK1 | 0.37641889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.60213111 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.47008511 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.44338974 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.43460512 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.32215048 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.11849640 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.03044896 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 1.97891828 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.89102931 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.88672049 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.88027194 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85005062 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.77481452 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 1.75387822 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.72907280 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.67987196 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 1.63388090 |
| 18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.56983516 |
| 19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.56208373 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.55122781 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.55059293 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.52079663 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.50421268 |
| 24 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.49754091 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49584828 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.49065627 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.48519254 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47544447 |
| 29 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.45043987 |
| 30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.44779932 |
| 31 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.43779800 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.43119477 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.39471724 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.39369226 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.39044991 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36920579 |
| 37 | Long-term potentiation_Homo sapiens_hsa04720 | 1.35641383 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.35272202 |
| 39 | Salivary secretion_Homo sapiens_hsa04970 | 1.31265995 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.23494541 |
| 41 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.20679607 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.18090693 |
| 43 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.17698449 |
| 44 | Huntingtons disease_Homo sapiens_hsa05016 | 1.12437029 |
| 45 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.11388856 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.11314123 |
| 47 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.11239246 |
| 48 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.10863656 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 1.09727975 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.09596657 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.07300555 |
| 52 | Renin secretion_Homo sapiens_hsa04924 | 1.06423089 |
| 53 | Cocaine addiction_Homo sapiens_hsa05030 | 1.04784123 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.03855313 |
| 55 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03687333 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 1.03138949 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.01245463 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 0.99104111 |
| 59 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.97131929 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.96596668 |
| 61 | Phototransduction_Homo sapiens_hsa04744 | 0.96201388 |
| 62 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.96092023 |
| 63 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.94550492 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93937783 |
| 65 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.93778147 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.93000407 |
| 67 | Long-term depression_Homo sapiens_hsa04730 | 0.91679575 |
| 68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.88331912 |
| 69 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.82664782 |
| 70 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.82498581 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.82281263 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82164909 |
| 73 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.81384000 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80020739 |
| 75 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78146269 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76839549 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.76608769 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.75546405 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74766680 |
| 80 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.73837693 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.73585125 |
| 82 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71195142 |
| 83 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71159308 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.69305952 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68818731 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68202807 |
| 87 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.66441376 |
| 88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.62648325 |
| 89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.62157410 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59613191 |
| 91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59315066 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57333986 |
| 93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.56822684 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56613337 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56052075 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55421137 |
| 97 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55352329 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54861828 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54846242 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54663995 |
| 101 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53623808 |
| 102 | Gap junction_Homo sapiens_hsa04540 | 0.53246467 |
| 103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53000129 |
| 104 | ABC transporters_Homo sapiens_hsa02010 | 0.51751705 |
| 105 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50153600 |
| 106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50149235 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49489071 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49165370 |
| 109 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.48904956 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48599108 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47291231 |
| 112 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.46563385 |
| 113 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46252113 |
| 114 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46169745 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43476418 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39813712 |
| 117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39011720 |
| 118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38483495 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38309900 |

